American Century Companies’s Corbus Pharmaceuticals CRBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$211K Buy
22,507
+7,368
+49% +$69.8K ﹤0.01% 2770
2026
Q1
$142K Buy
15,139
+1,728
+13% +$14.5K ﹤0.01% 2749
2025
Q4
$109K Buy
+13,411
New +$166K ﹤0.01% 2757

Other funds holding CRBP

American Century Companies's CRBP Position: Q2 2026 in Review

American Century Companies increased its Corbus Pharmaceuticals (CRBP) stake by 49% in Q2 2026, buying an estimated $69.8K and bringing the position to 22,507 shares worth $211K. The position accounts for ﹤0.01% of the portfolio, ranked #2770.

American Century Companies first reported a position in CRBP in Q4 2025 and has held it in 3 quarters since. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • American Century Companies held 22,507 shares of Corbus Pharmaceuticals worth $211K as of Q2 2026.
  • American Century Companies bought 7,368 Corbus Pharmaceuticals shares in Q2 2026, an estimated $69.8K.
  • Corbus Pharmaceuticals made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2770 holding.
  • American Century Companies first reported a position in Corbus Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.